Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Clinical Rheumatology|January 14, 2026
Use of biologic drugs in juvenile idiopathic arthritis patients followed in an adult rheumatology clinic: real-life data from the HUR-BIO biologic registryEmine Büşra Ata, Levent Kılıç, Büşra Fırlatan Yazgan, et al.
Rheumatology International|April 2, 2010
Assessment of latent tuberculosis infection in Takayasu arteritis with tuberculin skin test and Quantiferon-TB Gold testOmer Karadag, Kenan Aksu, Abdurrahman Sahin, et al.
Clinical Rheumatology|July 31, 2026
Efficacy and safety of leflunomide with tumor necrosis factor inhibitors in psoriatic arthritis: a retrospective analysisİbrahim Yahya Çakır, Emre Bilgin, Büşra Firlatan-Yazgan, et al.
Clinical and Experimental Rheumatology|January 27, 2022
Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life dataUmut Kalyoncu, Emre Bilgin, Abdulsamet Erden, et al.
Rheumatology and Therapy|June 9, 2023
Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO RegistryEmine Duran, Zeynep Ozge Ozturk, Emre Bilgin, et al.
Clinical and Experimental Rheumatology|September 8, 2020
Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective dataGezmiş Kimyon, Umut Kalyoncu, Sedat Kiraz, et al.
European Journal of Rheumatology|January 18, 2023
The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life DatabaseNilüfer Alpay Kanıtez, Sedat Kiraz, Ediz Dalkılıç, et al.
Clinical and Experimental Rheumatology|June 29, 2022
Clinical and laboratory factors associated with bamboo spine in patients with axial spondyloarthritis: are there clues for bamboo spine?Pamir Atagündüz, Sedat Kiraz, Servet Akar, et al.
Rheumatology International|April 29, 2022
Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?Ufuk İlgen, Ömer Karadağ, Hakan Emmungil, et al.
Clinical and Experimental Rheumatology|May 2, 2012
The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in TurkeySimten Malhan, Salih Pay, Sebnem Ataman, et al.
Pageof 12